SBIR Phase I: Development of a Commercial Culture of Dehalococcoides for Anaerobic Treatment of PCB's
SBIR 第一阶段:开发用于 PCB 厌氧处理的 Dehalococcoides 商业培养物
基本信息
- 批准号:1113457
- 负责人:
- 金额:$ 15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This Small BusinessI nnovationR esearch( SBIR) Phase1 project addressesth e developmento f abacterial culture to degrade PCBs (polychlorinated biphenyls) in contaminated soils andsediments. PCBs are persistent, toxic contaminants which accumulate in the fatty tissues ofanimals,c ontaminatingf ish and humans.P CB-degradingb acteriah ave beend ifficult to produce.In2009, a readily-grownb acterials peciesw as shownb y BioremediationC onsultingI nc (BCI) todegrade the most harmful and carcinogenic type of PCBs. This finding allows the developmentof an anaerobic PCB-degrading culture for cost-etfective inoculation into PCB-contaminatedsediments. The proposed research will document the ability of BCI's culture to extensivelydechlorinate three types of commercial PCB mixtures, and will develop methods of rapidculturing.The broader/commerciailm pactso f this researcha ret he developmento f a bacteriai noculantt hatwill degrade PCBs in soil and sediment. PCBs are toxic chemicals used historically as heatresistantfluids in many industrial applications, including transformers in the electric utilityindustry. Several hundred million pounds were manufactured and disposed, resulting incontamination of soils and river sediments. The recent finding at BCI, that a strain ofdechlorinating bacteria is capable of dechlorinating PCBs. provides an opportunity for BCI todevelop a commercial culture for inoculating contaminated sites with PCB-degrading bacteria.The marketing of this product will be complementedb y our already-successfusl aleso f otherdechlorinating cultures used in treatment of contamination by diverse chlorinated compounds.Major stakeholdersin the utility industries,a nd remediationc ontractors,h ave expressedin terestin partnering with BCI and/or obtaining culture.
这种小型企业nnovationr esearch(SBIR)阶段1项目地址为含量较高的含PCB(多氯联苯)在受污染的土壤和代码方面降低。 PCBs are persistent, toxic contaminants which accumulate in the fatty tissues ofanimals,c ontaminatingf ish and humans.P CB-degradingb acteriah ave beend ifficult to produce.In2009, a readily-grownb acterials peciesw as shownb y BioremediationC onsultingI nc (BCI) todegrade the most harmful and carcinogenic type PCB的。这一发现允许开发一种厌氧PCB降解培养物,以对PCB污染的种类进行成本感染接种。拟议的研究将记录BCI培养物广泛氯化三种类型的商业PCB混合物的能力,并将开发快速培养的方法。这项研究更广泛/更广泛/商业的方法。在许多工业应用中,PCB是历史上用作HeatresistantFluids的有毒化学物质,包括电力工具中的变压器。制造和处置了数亿磅,导致土壤和河流沉积物的灭火。最近在BCI的发现是,氯化细菌的菌株能够脱氯PCB。 provides an opportunity for BCI todevelop a commercial culture for inoculating contaminated sites with PCB-degrading bacteria.The marketing of this product will be complementedb y our already-successfusl aleso f otherdechlorinating cultures used in treatment of contamination by diverse chlorinated compounds.Major stakeholdersin the utility industries,a nd remediationc ontractors,h ave expressedin Terestin与BCI和/或获得文化合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret Findlay其他文献
Cesarean birth in the operating room
- DOI:
10.1016/s0001-2092(07)65893-1 - 发表时间:
1982-12-01 - 期刊:
- 影响因子:
- 作者:
Gail Hallmark;Margaret Findlay - 通讯作者:
Margaret Findlay
Margaret Findlay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret Findlay', 18)}}的其他基金
SBIR Phase I: Development and Characterization of a Bioaugmentation Culture to Remediate Chlorinated Ethenes in Low pH Ground Water
SBIR 第一阶段:修复低 pH 地下水中氯化乙烯的生物增强培养物的开发和表征
- 批准号:
0945557 - 财政年份:2010
- 资助金额:
$ 15万 - 项目类别:
Standard Grant
相似国自然基金
闪电先导和回击阶段针状结构发生发展特征差异研究
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
家庭处境不利青少年非自杀性自伤潜在发展结局预测及分阶段匹配干预研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
闪电先导和回击阶段针状结构发生发展特征差异研究
- 批准号:42275090
- 批准年份:2022
- 资助金额:55.00 万元
- 项目类别:面上项目
新发展阶段下相对贫困治理与共同富裕的耦合协同及其驱动机制研究
- 批准号:42271190
- 批准年份:2022
- 资助金额:49 万元
- 项目类别:面上项目
家庭处境不利青少年非自杀性自伤潜在发展结局预测及分阶段匹配干预研究
- 批准号:72204065
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
SBIR Phase I: Industrial-Scale Technology for Drug Development in Mature Human Fat Cells
SBIR 第一阶段:成熟人类脂肪细胞药物开发的工业规模技术
- 批准号:
2322443 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
Standard Grant
SBIR Phase I: Development of wearable medical device to detect and treat opioid overdose.
SBIR 第一阶段:开发可穿戴医疗设备来检测和治疗阿片类药物过量。
- 批准号:
2335577 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
Standard Grant
SBIR Phase II: Development of a Novel Measurement Technology to Enable Longitudinal Multiomic Investigations of the Gut Microbiome
SBIR 第二阶段:开发新型测量技术以实现肠道微生物组的纵向多组学研究
- 批准号:
2314685 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Development of a SERS-based diagnostic platform for multiplexing ubiquitous inflammatory markers in cancer.
SBIR 第一阶段:开发基于 SERS 的诊断平台,用于多重癌症中普遍存在的炎症标记物。
- 批准号:
2348543 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
Standard Grant
SBIR Phase II: Adaptable Ad Hoc Network Architecture for Rapid Infrastructure Development in Disaster Zones
SBIR 第二阶段:用于灾区快速基础设施开发的适应性 Ad Hoc 网络架构
- 批准号:
2322049 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Cooperative Agreement